Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZORO: IV Zanamivir vs Oseltamivir in Hospitalized Influenza
NCT01231620Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of zanamivir in influenza, sponsored by GSK. Started Jan 2011; status: completed.
02
Drugs
zanamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01231620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231620.